Cisplatin/paclitaxel vs. carboplatin/paclitaxel in 798 patients with ovarian cancer FIGO IIB-IV — Randomized phase III study the AGO (Arbeitsgemeinschaft Gynaekologische Onkologie) study group (OVAR-3 trial)

Authors :: S. D. Costa
Werner Meier
A. du Bois
Volker Moebus
W. Schroeder
S. Warms
S. Olbricht
Thomas Bauknecht
Barbara Richter
H. J. Lueck
Source :: European Journal of Cancer. 37:S325
Publication Year :: 2001
Publisher :: Elsevier BV, 2001.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Cisplatin/paclitaxel
business.industry
Internal medicine
medicine
business
Ovarian cancer
medicine.disease
Carboplatin/paclitaxel

Full Text Access

Tools